Valneva Statistics
NASDAQ: VALNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
5.16-0.205 (-3.82%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Valneva by the numbers
Valneva has a market capitalization of $490.9 million based on 95.13M shares outstanding. With trailing EPS of $-2.10, Valneva is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.6% below its 50-day average and 20.9% below its 200-day average.
Average daily trading volume is 23.10K shares, or about $119,196 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VALN valuation vs. peer median
| Metric | VALN | Peer median | Difference |
|---|---|---|---|
| Market cap | $490.86M | $474.93M | +3% |
| Avg. volume | 23.10K | 974.35K | -98% |
Peer median across 8 companies: DNA, SANA, RGNX, ETRA, FENC, IRLA, PROK, DBVT.
Valuation
- Market cap
- $490.86M
- Forward P/E
- 4.34
- EPS (TTM)
- $-2.10
- Shares outstanding
- 95.13M
Price and trading
- Previous close
- 5.37
- Open
- 5.30
- Day range
- 5.12 – 5.30
- 52-week range
- 4.75 – 12.18
- 52-week change
- -40.14%
- Beta
- —
- Volume
- 17.55K
- Average volume
- 23.10K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 24, 2026
Additional statistics
- Market Cap
- 490.86M
- Forward Pe
- 4.34
- Eps
- -2.10
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 12.18
- Week52 Low
- 4.75
- Avg Volume
- 23,100.00
- Shares Outstanding
- 95.13M
- Ma50
- 5.84
- Ma200
- 6.52
- Earnings Date
- Nov 24, 2026
- Pct From52w High
- -57.64%
- Pct From52w Low
- 8.63%